Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access |
Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc |
Journal website http://www.journalmc.org |
Case Report
Volume 6, Number 4, April 2015, pages 163-166
Sequential MRI, Cerebrospinal Fluid and Peripheral Blood Immunologic Analysis in a Natalizumab-Treated Patient With Progressive Multifocal Leukoencephalopathy
Figure
Table
Subset | Presentation | Week 6 | Week 15 | Week 31 |
---|---|---|---|---|
NP: not performed. | ||||
CSF activated %CD8+ | 59.56% (14.93%) | 29.11% (3.44%) | 24.68% (2.27%) | 29.44% (22.64%) |
PB activated %CD8+ | 30.28% (1.17%) | 20.92% (3.0%) | 27.00% (0.82%) | 3.64% (1.25%) |
CSF activated %CD4+ | 30.22% (8.89%) | 74.38% (5.30%) | 77.84% (1.98%) | 68.33% (21.14%) |
PB activated %CD4+ | 33.00% (8.89%) | 16.19% (17%) | 42.04% (0.99%) | 4.96% (2.34%) |
CSF activated %CD19+ | 0.35% (0.00%) | 16.67% (0.67%) | 24.71% (8.49%) | NP |
PB activated %CD19+ | 9.29% (7.80%) | 5.09% (39.21%) | 5.15% (3.22%) | 2.89% (27.62%) |
CSF %CD86+ pDCs | 0.83% (100.00%) | 0.56% (33.93%) | 1.14% (40.00%) | 2.88% (83.33%) |
PB %CD86+ pDCs | 0.17% (98.96%) | 0.09% (83.84%) | 0.09% (61.54%) | 0.04% (54.29%) |